ADC Biotechnology, an ADC contract services company offering conjugation technology designed to overcome process and aggregation challenges, has signed a partnership agreement with engineering specialists, WHP for the construction of a dedicated bioconjugation facility in Deeside, North Wales, UK. In September, ADC Bio secured $11 million in funding to establish manufacturing operations for the supply of ADCs for human clinical trials. The new facilities, scheduled to be operational in Septem...